Is technological change in medicine worth it?

By David M. Cutler, M. McClellan. Health Affairs, 2001

956 citations recorded by the source corpus.

Subfields: Economics and Econometrics, General Health Professions

View Paper: https://www.semanticscholar.org/paper/4568c14418996d865cbdd8c9006fbf6360a8052d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

In General Health Professions

Citations in the corpus

The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003, background): “Moreover, the effectiveness of specific interventions in cardiovascular disease, neonatal care, and cancer treatment has been used to argue that the overall gains from increased spending are worth the costs (3) and that any constraints on the expansion of the specialist workforce or on further spend”
Determinants of U.S. health expenditure: Evidence from autoregressive distributed lag (ARDL) approach to cointegration (2016, background): “Moreover, Cutler and McClellan (2001a, 2001b) claim that technological progress in health care escalates health spending in two ways, the “treatment substitution effect” and the “treatment expansion effect”.”
The Aging Population and Its Impact on the Surgery Workforce (2003, background): “The rapid growth of coronary angioplasty and stent technology had no discernible impact on the growth of coronary artery bypass surgery.(21) It remains to be seen whether other nonsurgical therapies (eg, proton pump inhibitors, carotid artery stents) will affect rates of surgeries in the future (eg,”
Gross National Happiness As an Answer to the Easterlin Paradox (2008, methodology): “The literature on the relationship between income and happiness includes (besides the papers cited above) Winkelmann and Winkelmann (1998) who use individual panel data for Germany, Di Tella et al. (2003) who look at the evidence on changes in income across a panel of 12 OECD countries and Gardner a”
The relationship between innovation and subjective wellbeing (2012, background): “For example, Cutler and McClellan (2001) found that innovations in the treatment of heart attacks, low birth-weight infants, depression, cataracts, and breast cancer have led to increased longevity and less absenteeism from the workplace.”
The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care (2003, background): “Policymakers argue (and the public assumes) that any constraints on growth are likely to be harmful (1, 2).”